Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis

Journal of Clinical Rheumatology

Volumn 17, Issue 8, 2011, Pages 421-423

  Skare, Thelma S ^a   Nisihara, Renato M ^a,b   Silva, Rafael Mourato ^a   Munhoz Da Silva, Danilo J ^a   Gameiro Silva, Marilia B ^a   Utiyama, Shirley R R ^b  

^a Evangelical University Hospital of Curitiba   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

anti CCP; juvenile idiopathic arthritis; prognosis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; ONSET AGE; POLYARTHRITIS; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, JUVENILE RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PROGNOSIS; RHEUMATOID FACTOR; YOUNG ADULT;

EID: 82455199026     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31823a4d0a     Document Type: Article

References (23)

1. Weiss JE, Ilowite NT. Juvenile idiopathic arthritis. Rheum Dis Clin N Am 2007;33:441-470.
2. Foster HE, Marshall N, Myers A, et al. Outcome in adults with juvenile rheumatoid arthritis. A quality of life study. Arthritis Rheum 2003;48:767-775.
3. Van Rossum MJA, Zwinderman AH, Bohers M, et al. Radiologic features in juvenile idiopathic arthritis: A first step in the development of standardizes assessment method. Arthritis Rheum 2003;48:507-508.
4. Gilliam BE, Chauhan AK, Low JM, et al. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: A comparative study. Clin Exp Rheumatol 2008;26:492-497.
5. Petty RE, Cassidy GT, Sullivan DB. Clinical correlates of antinuclear antibodies in juvenile rheumatoid arthritis. J Pediatr 1973;83:386-389.
6. Lee AN, Beck CE, Hall M. Rheumatoid factor and anti-CCP antibodies in rheumatoid arthritis: A review. Clin Lab Sci 2008;21:15-18.
7. Brunner J, Sitzmann FC. The diagnosis value of anti cyclic citrullinated peptide (CCP) antibodies in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2006;24:449-551.
8. Ferucci ED, Majka DS, Parrish L, et al. Antibodies against cyclic citrullinated peptide are associated with HLA DR4 in simplex and multiplex polyarticular onset juvenile rheumatoid arthritis. Arthritis Rheum 2005;52:239-246.
9. Gupta R, Thabah MM, Vaidya B, et al. Anti cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Indian J Pediatr 2010;77:41-44.
10. Machado SH, von Mühlen CA, Brenol JCT, et al. The prevalence of anti cyclic citrullinated antibodies in juvenile idiopathic arthritis. J Pediatr (Rio J) 2005;81:491-494.
11. Kasapopur Ö , Altun S, Karaarslan S, et al. Diagnostic accuracy of anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2003;63:1687-1689.
12. Habib HM, Mosaad YM, Youssef HM. Anti cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Immunol Invest 2008;37:849-857.
13. Van Rossum M, van Soesbergen R, de Kort S, et al. Anti cyclic citrullinated peptide (anti CCP) antibodies in children with idiopathic arthritis J Rheumatol 2003;30:825-828.
14. Petty RE, South wood TR, Baum J. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban,1997. J Rheumatol 1998;25:1991-1994.
15. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
16. Klippel JH, Dieppe PA. Selected measures for outcome assessment of rheumatic diseases. In: Klippel JH, Dieppe PA, eds. Rheumatology. 2nd ed. London, UK: Mosby; 1998 vol.2, S-A:1-12.
17. Minden K. Adult outcomes of patients with juvenile idiopathic arthritis. Horm Res 2009;1:20-25.
18. Tucker LB, Cabral DA. Transition of the adolescent patients with rheumatic disease: Issues to consider. Rheum Dis N Am 2007;33:661-672.
19. Zak M, Pedersen FK. Juvenile chronic arthritis into adulthood: A long term follow up study. Rheumatology 2000;39:198-204.
20. Hromadnikova I, Stechova K, Vavrincova P, et al. Anti cyclic citrullinated antibodies in patients with juvenile idiopathic arthritis. Autoimmunity 2002;35:397-401.
21. Avcin T, Cimaz R, Falcini F, et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2002;61:608-611.
22. Dewint P, Hoffman EA, Rogge S, et al. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. Rheumatology 2006;45:204-208.
23. Bizzaro N, Mazzanti G, Tonutti E, et al. Diagnostic accuracy of the anti-citrullinated antibody assay for rheumatoid arthritis. Clin Chem 2001;47:1089-1093.